Leishmania treatment and prevention: Natural and synthesized drugs

被引：78

作者：

Bekhit, Adnan A. ^{[1
,2
]}

El-Agroudy, Eman ^{[1
]}

Helmy, Aliaa ^{[3
]}

Ibrahim, Tamer M. ^{[4
]}

Shavandi, Amin ^{[5
,6
]}

Bekhit, Alaa El-Din A. ^{[7
]}

机构：

[1] Alexandria Univ, Dept Pharmaceut Chem, Fac Pharm, Alexandria 21521, Egypt

[2] Univ Bahrain, Coll Hlth Sci, Allied Hlth Dept, Pharm Program, POB 32038, Zallaq, Bahrain

[3] Alexandria Univ, Fac Pharm, Alexandria 21521, Egypt

[4] Kafrelsheikh Univ, Dept Pharmaceut Chem, Fac Pharm, Kafr Al Sheikh 33516, Egypt

[5] Univ Otago, Ctr Mat Sci & Technol, Dunedin, New Zealand

[6] Univ Libre Bruxelles, Interfac Sch Bioengineers, Brussels, Belgium

[7] Univ Otago, Dept Food Sci, Dunedin, New Zealand

来源：

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY | 2018年 / 160卷

关键词：

Leishmaniasis; Herbal agents; Synthesized agents; Antileishmanial targets; Vaccination trials; VITRO ANTILEISHMANIAL ACTIVITY; AZAR DERMAL LEISHMANIASIS; IN-VITRO; VISCERAL LEISHMANIASIS; CUTANEOUS LEISHMANIASIS; DNA CLEAVAGE; ARTEMISININ DERIVATIVES; MUCOSAL LEISHMANIASIS; QUINOLINE ALKALOIDS; TOPOISOMERASE-I;

D O I：

10.1016/j.ejmech.2018.10.022

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Leishmaniasis affects over 150 million people all over the world, especially in subtropical regions. Currently used antileishmanial synthesized drugs are associated with some drawbacks such as resistance and cytotoxicity, which hamper the chances of treatment. Furthermore, effective leishmanial vaccines are not well developed. Promising chemotherapy, either from natural or synthetic compounds, was or still is the most promising treatment. This review focuses on recent findings in drugs used for the treatment of leishmaniasis including; chemical and natural antileishmanial moieties, different potential targets, as well as various trials of vaccination development. Special emphasis has been paid to the mechanisms of the drugs, their safety and where possible, the structure-activity relationship to enable guided future drug discovery. (C) 2018 Elsevier Masson SAS. All rights reserved.

引用

页码：229 / 244

页数：16

共 198 条

[1]

Abdu Tuha Abdu Tuha, 2017, African Journal of Pharmacy and Pharmacology, V11, P32, DOI 10.5897/AJPP2016.4401

[2] Triazolopyridyl ketones as a novel class of antileishmanial agents. DNA binding and BSA interaction [J].